Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

M-013

Supelco

(±)-MDMA solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Synonyme(s) :

(±)-3,4-Methylenedioxymethamphetamine

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Formule empirique (notation de Hill):
C11H15NO2
Numéro CAS:
Poids moléculaire :
193.24
Numéro CE :
Numéro MDL:
Code UNSPSC :
41116107
ID de substance PubChem :
Nomenclature NACRES :
NA.24

Qualité

certified reference material

Niveau de qualité

Forme

liquid

Caractéristiques

Snap-N-Spike®/Snap-N-Shoot®

Conditionnement

ampule of 1 mL

Fabricant/nom de marque

Cerilliant®

drug control

Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIA (Portugal)

Concentration

1.0 mg/mL in methanol

Technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Application(s)

forensics and toxicology

Format

single component solution

Température de stockage

−20°C

Chaîne SMILES 

CC(CC1=CC=C(OCO2)C2=C1)NC

InChI

1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3

Clé InChI

SHXWCVYOXRDMCX-UHFFFAOYSA-N

Catégories apparentées

Description générale

This certified Snap-N-Spike® Solution is suitable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications from forensic analysis and clinical toxicology to urine drug testing.

(±)-3,4-Methylenedioxymethamphetamine (MDMA) belongs to the class of racemic amphetamine-type stimulant drugs. It has psychoactive properties and is an active ingredient of the synthetic hallucinogenic drug, ecstasy. It is an illicit drug known by a variety of street names, including "Ecstasy," "E," "X," and "XTC". An analog of the phenethylamine class, MDMA is abused for its euphoric and psychedelic effects.

Application

The Certified Reference Material (CRM) in solution can also be used as follows:
  • Electrochemical detection of morphine and MDMA from human serum and urine samples using a sensitive sensor based on platinum nanoparticles deposited on carbon nanohorns (CNHs)
  • Enantiomeric assessment of seized drugs of amphetamine, methamphetamine, and MDMA by two methods of liquid chromatography coupled with tandem mass spectrometry (MS/MS) and diode array detector (DAD)
  • Development and validation of a stereoselective liquid chromatography-tandem mass spectrometric (LC-MS/MS) procedure for the analysis of MDMA and its metabolites in human plasma samples
  • Matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometric (MALDI-QqQ-MS/MS) based analysis of MDMA and its metabolite 3,4-methylenedioxyamphetamine in oral fluid samples
  • Differential pulse voltametric (DPV) identification and quantification of MDMA in seized drug samples using boron-doped diamond electrode (BDDE)

Caractéristiques et avantages

  • Fully characterized under ISO/IEC 17025 and ISO 17034 accreditation
  • Accompanied with a comprehensive Certificate of Analysis (CoA) with data on stability, homogeneity, accuracy of concentration, uncertainty, and traceability
  • Rigorously tested through real-time stability studies to ensure accuracy and shelf life
  • Gravimetrically prepared using qualified precision balances to ensure minimal uncertainty
  • Flame sealed under argon into ampoules for long-term shelf life
  • Offered in a convenient, DEA-exempt format to improve laboratory efficiency

Produits recommandés

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

Pictogrammes

FlameSkull and crossbonesHealth hazard

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Organes cibles

Eyes,Central nervous system

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

49.5 °F - closed cup

Point d'éclair (°C)

9.7 °C - closed cup


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Re: "Spice, bath salts, and the U.S. Military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces".
Peter L Platteborze et al.
Military medicine, 178(1), v-v (2013-01-30)
Clifton Chow et al.
Culture, health & sexuality, 15(3), 311-326 (2013-01-15)
Research shows that sexual minorities are at greater risk for illicit substance use and related harm than their heterosexual counterparts. This study examines a group of active drug users to assess whether sexual identity predicts increased risk of substance use
Courtney Huff et al.
Brain research bulletin, 91, 52-57 (2013-01-16)
Recent studies have demonstrated that a preconditioning regimen (i.e., repeated low doses) of MDMA provides protection against the reductions in tissue concentrations of 5-HT and 5-HT transporter (SERT) density and/or expression produced by a subsequent binge regimen of MDMA. In
Takuya Shimane et al.
Psychiatry and clinical neurosciences, 67(1), 12-19 (2013-01-22)
The aim of this study was to examine the prevalence of 3, 4-methylenedioxymethamphetamine (MDMA) use and to identify characteristics of MDMA users among rave attendees in Japan. This is the first rave-population study focusing on MDMA use in Japan. The
Gabrielle Todd et al.
PloS one, 8(2), e56438-e56438 (2013-02-19)
Use of illicit stimulants such as methamphetamine, cocaine, and ecstasy is an increasing health problem. Chronic use can cause neurotoxicity in animals and humans but the long-term consequences are not well understood. The aim of the current study was to

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique